These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36522371)

  • 1. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
    Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
    Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
    Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
    Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
    Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
    Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
    Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
    Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
    Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin.
    Zanaruddin SN; Yee PS; Hor SY; Kong YH; Ghani WM; Mustafa WM; Zain RB; Prime SS; Rahman ZA; Cheong SC
    PLoS One; 2013; 8(11):e80229. PubMed ID: 24224046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
    Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
    Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
    Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.
    Agrawal N; Frederick MJ; Pickering CR; Bettegowda C; Chang K; Li RJ; Fakhry C; Xie TX; Zhang J; Wang J; Zhang N; El-Naggar AK; Jasser SA; Weinstein JN; Treviño L; Drummond JA; Muzny DM; Wu Y; Wood LD; Hruban RH; Westra WH; Koch WM; Califano JA; Gibbs RA; Sidransky D; Vogelstein B; Velculescu VE; Papadopoulos N; Wheeler DA; Kinzler KW; Myers JN
    Science; 2011 Aug; 333(6046):1154-7. PubMed ID: 21798897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review).
    Li M; Sun D; Song N; Chen X; Zhang X; Zheng W; Yu Y; Han C
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37449494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia.
    Sawada K; Momose S; Kawano R; Kohda M; Irié T; Mishima K; Kaneko T; Horie N; Okazaki Y; Higashi M; Tamaru JI
    Mod Pathol; 2022 Feb; 35(2):177-185. PubMed ID: 34404905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from next-generation sequencing in head and neck cancer.
    Loyo M; Li RJ; Bettegowda C; Pickering CR; Frederick MJ; Myers JN; Agrawal N
    Head Neck; 2013 Mar; 35(3):454-63. PubMed ID: 22907887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H).
    Li Z; Gonzalez CL; Wang B; Zhang Y; Mejia O; Katsonis P; Lichtarge O; Myers JN; El-Naggar AK; Caulin C
    J Pathol; 2016 Oct; 240(2):224-34. PubMed ID: 27447534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
    Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
    Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
    Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
    Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
    Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
    Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
    Batta N; Pandey M
    World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.